Meeting
2011 ASCO Annual Meeting
Screening for hepatitis B virus (HBV) prior to chemotherapy: A cost-effectiveness analysis.
Authors
U. Zurawska
University of Toronto, Toronto, ON, Canada
U. Zurawska , L. K. Hicks , G. Woo , C. M. Bell , M. Krahn , K. K. Chan , J. J. Feld
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Health Services Research
Citation
J Clin Oncol 29: 2011 (suppl; abstr 6059)
Abstract #
6059
Poster Bd #
42G
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Hepatitis B virus screening before adjuvant chemotherapy in patients with early stage breast cancer: A cost-effectiveness analysis.
First Author: William W. L. Wong
Poster
2022 ASCO Quality Care Symposium
Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.
First Author: Sarah J. Mah
Poster
2022 ASCO Quality Care Symposium
Changing the electronic health record to optimize pre-chemotherapy lab orders.
First Author: Barbara Lam
Poster
2018 ASCO Quality Care Symposium
Implementation of a hepatitis B screening process prior to CD20 therapy treatment in an oncology practice.
First Author: Ali McBride